Results 81 to 90 of about 1,680 (126)

Severe hemophilia A with inhibitors and pancreatic cancer - when emicizumab is not enough. [PDF]

Blood Transfus
Biglietto M, Linari S, Faccini AL, Sorella S, Crisanti E, Antonacci M, Ligia S, Mormile R, Ciciani R, Baldacci E, Santoro C.   +10 more
europepmc   +1 more source

Post‑Marketing Surveillance of the Safety and Effectiveness of Emicizumab in Japanese Patients With Congenital Haemophilia A With Inhibitors. [PDF]

Haemophilia
Shima M, Fukutake K, Matsumoto M, Sugimura Y, Sugita C, Ji L, Kawano M, Matsushita T.   +7 more
europepmc   +1 more source

Emicizumab in infants: not just cost-effective but mandatory. [PDF]

Blood Adv
Young G.
europepmc   +1 more source

Successful hemodialysis initiation in acquired hemophilia a managed with susoctocog alfa and emicizumab. [PDF]

CEN Case Rep
Kihara A, Tamaki M, Sumitani R, Okinari C, Tada M, Miyakami S, Yamaguchi S, Inagaki T, Minato M, Shibata E, Hasegawa K, Wakino S.   +11 more
europepmc   +1 more source

From pharmacokinetic-guided FVIII prophylaxis to low-dose Emicizumab prophylaxis: a pilot study revealed a flush of hope. [PDF]

Ann Hematol
Ye J, Huang K.
europepmc   +1 more source

Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study. [PDF]

Haemophilia
Buckner TW, Carpenter SL, Daoud N, Kempton CL, Lee L, Malec L, McLean TW, Morton P, O'Neill C, Staber JM, Wang M, Croteau SE, Recht M.   +12 more
europepmc   +1 more source

NuPOWER (Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis): protocol for an open-label, single-arm, multicentre study. [PDF]

BMJ Open
Srivastava A, Kanny A, Langer F, Kubicek-Hofmann C, Álvarez Román MT, Núñez Vázquez R, Boban A, Dejanova-Ilijevska V, Miljić P, Garcia J, Halimeh S, Drillaud N, Valentin JB, Mancuso ME, Castaman G, Santoro RC, Lehtinen AE, Abraham A, Hashimoto M, Knaub S.   +19 more
europepmc   +1 more source

Postpartum acquired hemophilia presenting as compartment syndrome: a diagnostic challenge in the emergency department. [PDF]

Int J Emerg Med
Mujahed W, Nama A, Kalish J, Nimer Q, Hahn B, Alpert EA.   +5 more
europepmc   +1 more source

Deferral of immunosuppression in acquired hemophilia. [PDF]

Blood Adv
Teitel J, St-Louis J.
europepmc   +1 more source

Cost-effectiveness of emicizumab for the treatment of hemophilia A: a systematic review. [PDF]

Front Public Health
Chen M, Lin Y, He G, Huang L, Han J, Ni J.   +5 more
europepmc   +1 more source